JP2011503109A5 - - Google Patents

Download PDF

Info

Publication number
JP2011503109A5
JP2011503109A5 JP2010533329A JP2010533329A JP2011503109A5 JP 2011503109 A5 JP2011503109 A5 JP 2011503109A5 JP 2010533329 A JP2010533329 A JP 2010533329A JP 2010533329 A JP2010533329 A JP 2010533329A JP 2011503109 A5 JP2011503109 A5 JP 2011503109A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
dose
corticosteroid
triamcinolone
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010533329A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011503109A (ja
JP5537434B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/083059 external-priority patent/WO2009062193A2/en
Publication of JP2011503109A publication Critical patent/JP2011503109A/ja
Publication of JP2011503109A5 publication Critical patent/JP2011503109A5/ja
Application granted granted Critical
Publication of JP5537434B2 publication Critical patent/JP5537434B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010533329A 2007-11-09 2008-11-10 コルチコステロイド製剤を投与する方法 Expired - Fee Related JP5537434B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US264507P 2007-11-09 2007-11-09
US61/002,645 2007-11-09
US6949808P 2008-03-14 2008-03-14
US61/069,498 2008-03-14
PCT/US2008/083059 WO2009062193A2 (en) 2007-11-09 2008-11-10 Methods for administering corticosteroid formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013167360A Division JP2013227351A (ja) 2007-11-09 2013-08-12 コルチコステロイド製剤を投与する方法

Publications (3)

Publication Number Publication Date
JP2011503109A JP2011503109A (ja) 2011-01-27
JP2011503109A5 true JP2011503109A5 (enExample) 2012-01-05
JP5537434B2 JP5537434B2 (ja) 2014-07-02

Family

ID=40377556

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010533329A Expired - Fee Related JP5537434B2 (ja) 2007-11-09 2008-11-10 コルチコステロイド製剤を投与する方法
JP2013167360A Pending JP2013227351A (ja) 2007-11-09 2013-08-12 コルチコステロイド製剤を投与する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013167360A Pending JP2013227351A (ja) 2007-11-09 2013-08-12 コルチコステロイド製剤を投与する方法

Country Status (8)

Country Link
US (2) US20090149432A1 (enExample)
EP (1) EP2207527A2 (enExample)
JP (2) JP5537434B2 (enExample)
AU (1) AU2008323676B2 (enExample)
CA (1) CA2705159A1 (enExample)
IL (1) IL205644A0 (enExample)
MX (1) MX2010005100A (enExample)
WO (1) WO2009062193A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2618816A4 (en) * 2010-09-22 2014-10-29 Map Pharmaceuticals Ltd AEROSOL COMPOSITION FOR THE ADMINISTRATION OF MEDICAMENTS
ES2913339T3 (es) * 2014-01-31 2022-06-01 Draka Elevator Products Inc Dispositivo sensor de detección sísmica para equipo de transporte vertical
US20210283145A1 (en) * 2020-03-13 2021-09-16 Softhale Nv Method for the treatment of viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW497974B (en) * 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
BRPI0418276B8 (pt) * 2003-12-31 2021-05-25 Cydex Pharmaceuticals Inc formulação líquida inalável compreeendendo budesonida
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178051A1 (en) * 2006-01-27 2007-08-02 Elan Pharma International, Ltd. Sterilized nanoparticulate glucocorticosteroid formulations

Similar Documents

Publication Publication Date Title
HRP20200495T1 (hr) Sastavi za liječenje gastrointestinalne upale
JP2008505978A5 (enExample)
WO2013003731A2 (en) Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence
JP2011502172A5 (enExample)
Rasheed et al. A review of natural steroids and their applications
WO2013061269A1 (en) Combinations of loteprednol and olopatadine for the treatment of ocular allergies
DK2403503T3 (en) Methods for the treatment of ocular inflammatory diseases
HRP20161279T1 (hr) Kombinirani preparati s antagonistom citokina i ortikosteroidom
US20120067343A1 (en) Aerosol Composition for Administering Drugs
JP2023530166A5 (enExample)
JP2006518382A5 (enExample)
RU2005129276A (ru) Применение стероидов для лечения субъектов, страдающих заболеванием глаз
JP2006505562A5 (enExample)
RU2017129432A (ru) Лекарственные препараты для жирового тела сустава и способы их применения
JP2023546361A5 (enExample)
JP2005508983A5 (enExample)
RS52672B2 (sr) Tretman reumatoidnih bolesti glukokortikoidom sa odloženim-oslobađanjem
JP2024519196A5 (enExample)
US20160220583A1 (en) Aqueous nasal spray composition of corticosteroids and antihistaminic agents
TW200920380A (en) Therapeutic regimens for the treatment of immunoinflammatory disorders
AU2008323676B2 (en) Methods for administering corticosteroid formulations
US20210386716A1 (en) Compositions and methods for blocking the cytokine storm of coronavirus and other medical conditions
JP2022551499A5 (enExample)
RU2007124549A (ru) Средство, усиливающее действие адренокортикоидов, содержащее аравийскую камедь
CN102309756A (zh) 含有磷酸二酯酶4抑制剂和糖皮质激素的治疗皮肤病的复方药物